<DOC>
	<DOCNO>NCT02156492</DOCNO>
	<brief_summary>The main purpose study investigate body respond evacetrapib evaluate safety effect evacetrapib , alone combination select statin , healthy Chinese participant . The study 2 part . Part one last 4 week part two last 5 week , include screen . Participants may enroll one part .</brief_summary>
	<brief_title>A Study Evacetrapib With Selected Statins Healthy Chinese Participants</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Evacetrapib</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Are native Chinese living China . Are overtly healthy male female determine medical history physical examination . Female participant : Women childbearing potential Women childbearing potential must correctly use 2 form reliable contraception avoid get pregnant study 3 month study complete . Body Mass Index : 19.0 24.0 kilogram per square meter ( kg/m^2 ) BP pulse rate supine stand position approximately systolic BP ≤ 140 milimeter mercury ( mm Hg ) , diastolic BP ≤ 90 mm Hg Participants untreated hypercholesterolemia may include herbal traditional Chinese medicine ( TCM ) Have know liver disease Have give write informed consent Are currently enrol clinical trial involve investigational product ( IP ) offlabel use drug device , concurrently enrol type medical research judge scientifically medically compatible study . Have know allergy evacetrapib , simvastatin , atorvastatin , related compound component formulation Have previously complete withdrawn study study investigate evacetrapib , previously receive IP within 3 month . Have history within last year presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematologic , neurologic disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data . Show evidence significant active neuropsychiatric disease . Regularly use know drug abuse Are woman positive pregnancy test woman lactate . Have use intend use overthecounter prescription medication ( include vitamins/mineral supplement ) TCM 14 day prior first dose study . Hormonal contraceptive permit . Use drug substance know substrate , inducer , inhibitor organic anion transport polypeptide 1B1 ( OATP1B1 ) , transporter involve simvastatin atorvastatin disposition , drug substance know strong inducer inhibitor cytochrome P450 3A ( CYP3A ) within 30 day prior first dose throughout study . Donated blood &gt; 400 mL within last month . Drink alcoholic beverage intake exceeds 28 unit per week ( male ) 21 unit per week ( female ) , unwilling stop alcohol consumption 48 hour prior dose discharge clinical research unit ( CRU ) ( 1 unit = 12 oz 360 mL beer ; 5 oz 150 mL wine ; 1.5 oz 45 mL distilled spirit ) . Are unwilling comply dietary requirements/restrictions study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>